Therapy

http://www.MeTheDoctor.com/sweaty-palms — Cure Sweaty Palms — How to Successfully Cure Sweaty Palms for Good

How to cure sweaty palms is a question asked frequently by the numerous individuals who suffer from this often times embarrassing condition.

Having persistent excessively sweaty palms is typically caused by a condition known as “palmar hyperhidrosis”.

This condition can significantly interfere with the quality of ones life as many will avoid social situations in fear of having to shake hands and often suffer embarrassment at work or other situations when the excess sweat from their palms causes paper products to become wet, soil electronic devices, and causes difficulty when holding items that become slippery from sweat.

While there are many over-the-counter remedies, prescription medications and surgical procedures, these often only provide a temporary relief and sometimes cause uncomfortable side effects.

However, many individuals have found success in eliminating their sweaty palms with alternative forms of treatment including natural remedies and therapeutic treatments including iontophoresis.

If you would like the details on how to cure sweaty palms without using medications or having a surgical procedure, you can do so by visiting us at: http://www.MeTheDoctor.com/sweaty-palms

Duration : 0:2:48

Read the rest of this entry »

Lysergic acid diethylamide, abbreviated LSD or LSD-25, also known as lysergide and colloquially as acid, is a semisynthetic psychedelic drug of the ergoline and tryptamine families. LSD is non-addictive, non-toxic, and is well known for its psychological effects which can include altered thinking processes, closed and open eye visuals, synaesthesia, a sense of time distortion, ego death and spiritual experiences, as well as for its key role in 1960s counterculture. It is used mainly by psychonauts as an entheogen, recreational drug and as an agent in psychedelic therapy.

LSD was first synthesized by Albert Hofmann in 1938 from ergot, a grain fungus that typically grows on rye. The short form LSD comes from its early code name LSD-25, which is an abbreviation for the German “Lysergsäure-diethylamid” followed by a sequential number. LSD is sensitive to oxygen, ultraviolet light, and chlorine, especially in solution, though its potency may last for years if it is stored away from light and moisture at low temperature. In pure form it is a colorless, odorless, and mildly bitter solid. LSD is typically delivered orally, usually on a substrate such as absorbent blotter paper, a sugar cube, or gelatin. In its liquid form, it can also be administered by intramuscular or intravenous injection. LSD is very potent, with 2030 µg (micrograms) being the threshold dose.

Introduced by Sandoz Laboratories, with trade-name Delysid, as a drug with various psychiatric uses in 1947, LSD quickly became a therapeutic agent that appeared to show great promise. However, the emerging recreational use of the drug by youth culture in the Western world during the 1960s led to a political firestorm that resulted in its prohibition. A number of organizations—including the Beckley Foundation, MAPS, Heffter Research Institute and the Albert Hofmann Foundation—exist to fund, encourage and coordinate research into its medicinal uses.

LSD was first synthesized on November 16, 1938 by Swiss chemist Dr. Albert Hofmann at the Sandoz Laboratories in Basel, Switzerland as part of a large research program searching for medically useful ergot alkaloid derivatives. LSD’s psychedelic properties were discovered 5 years later when Hofmann accidentally ingested an unknown quantity of the chemical. The first intentional ingestion of LSD occurred on April 19, 1943, when Dr. Hofmann ingested 250 µg of LSD. He hypothesized this would be a threshold dose based on the dosages of other ergot alkaloids. Hofmann found the effects to be much stronger than he anticipated. Sandoz Laboratories introduced LSD as a psychiatric drug in 1947.

Beginning in the 1950s the US Central Intelligence Agency began a research program code named Project MKULTRA. Experiments included administering LSD to CIA employees, military personnel, doctors, other government agents, prostitutes, mentally ill patients, and members of the general public in order to study their reactions, usually without the subject’s knowledge. The project was revealed in the US congressional Rockefeller Commission report in 1975.

In 1963 the Sandoz patents expired on LSD. Also in 1963, the US Food and Drug Administration classified LSD as an Investigational New Drug, which meant new restrictions on medical and scientific use. Several figures, including Aldous Huxley, Timothy Leary, and Al Hubbard, began to advocate the use of LSD. LSD became central to the counterculture of the 1960s. On October 24, 1968, possession of LSD was made illegal in the United States. The last FDA approved human study with LSD, for use in dying cancer patients, ended in 1980. Legally approved and regulated psychiatric use of LSD continued in Switzerland until 1993. Today, medical research is resuming around the world.

Duration : 0:9:59

Read the rest of this entry »

Title: STUDY ON THE PROTECTIVE EFFECT OF METHANOLIC EXTRACT OF MENTHA ARVENSIS L. LEAVES ON HALOPERIDOL INDUCED EXTRAPYRAMIDAL MOVEMENT DISORDERS IN ALBINO RATS

Description:

Anti-psychotics are the drugs used to treat schizophrenia. Typical anti-psychotics like haloperidol produce serious side effects called extrapyramidal movement disorders (EPS)
(catalepsy, tardive dyskinesia, acute dystonia, exploratory behaviour etc.), leading to patient noncompliance and loss of quality of life. These EPS are due to pro-oxidant property of haloperidol which causes oxidative stress induced neuronal damage. So, by the use of anti-oxidants EPS can be reduced.
In the present study, EPS are induced in four groups of albino rats by treating with haloperidol for 21 days,at a dose of 1mg/kg I.P. On the 22nd day three groups of albino rats were treated with MEMA 200mg/kg, 400mg/kg, 600mg/kg respectively. After 30 minutes of administration,haloperidol was injected. The fourth group was treated with haloperidol alone. The therapeutic effect of MEMA on haloperidol induced adverse effects was determined by various methods like hole board test, cataleptic score, and vacuous chewing movements and comparing the (Haloperidol+MEMA) treated groups with Haloperidol treated group.
High dose of MEMA showed a beneficiary effect by reducing the haloperidol induced adverse effects in albino rats. Thus, supplementation of MEMA along with haloperidol showed a protective effect over oxidative stress induced neuronal damage in albino rats.

Duration : 0:2:41

Read the rest of this entry »

Welcome to The Daily Stock Report…brought to you by QualityStocks.Net, performance tracked daily.

I’m Cathy Rankin and for Friday June 29th we’re bringing you the latest news from around the markets as well as the top movers to look out for today…

(HEADLINE NEWS)

Let’s get into some of the top movers and shakers on the Quality Stocks watch list specifically what was going on last week…

Today’s report is brought to you today by Cord Blood America, Inc., (CBAI.OB)

Cord Blood America, Inc., (CBAI.OB) through its wholly owned subsidiary, Cord Partners, Inc., engages in the collection, testing, processing, and preservation of umbilical cord blood in the United States. This blood enables families to preserve cord blood at the birth of a child for use in future stem cell therapy, which uses live cells as therapeutic agents to treat disease.

nCoat, Inc. (NCOA.OB) announced that its subsidiary, High Performance Coatings, Inc. has entered a collaborative agreement with Universal Technical Institute, to train automotive engineers on the performance and use of coatings. The tests could show the benefit a high performance coating can bring to exhaust system designs in the schools, which study state-of-the-art nano-coating and micron particulate coating technology.

nCoat, Inc. is an emerging nanotechnology company with new nano-formulated and traditional coatings that make it an international leader in the development and marketing of coatings applied to metal, ceramics, fabric, and other materials.

Wi-Fi TV Inc. (WTVI.PK) announced Thursday that its URL will take new iPhone® users directly to Wi-Fi TV Inc.’s page of live content optimized for the iPhone®. The link will tie-in with the launch of a 24/7 multiplex style movie marathon which will be presented, along with the live TV stations accessible over the iPhone®.

Wi-Fi TV Inc. provides a new generation TV delivery platform that has a geographic sphere that will out-distance any traditional cable or over-the-air TV broadcaster. The Wi-Fi TV website is the only place on the Internet where you can watch hundreds of TV stations and chat with others watching the same program.

Sweet Success Enterprises (SWTS.OB) shares were boosted on yesterday’s announcement that all seven (7) of the Sweet Success ready-to-drink beverages will be available for sale on Samsclub.com beginning July 1, 2007.
Amazon.com, announced it has received its latest shipment of all products and should have them available in their system shortly.

Sweet Success Enterprises, Inc. engages in the production, distribution, and marketing of ready-to-drink functional health beverages.

Pacific Biometrics, Inc. (PBME.OB) announced Wednesday the company has been awarded a contract worth an estimated $610,000 with a top multinational pharmaceutical company. The contact is for the study of a biological treatment for rheumatoid arthritis (RA), which will provide essential laboratory data for a pivotal, global Phase III program.

And that’s our newsmakers, Stay tuned right here to Quality Stocks Daily for the latest news from small cap to large cap, and everything in by QualityStocks.Net, where performance is tracked daily.

Thank you for tuning in, I’m Cathy Rankin, Have a great day and we’ll see you tomorrow, right here on the daily report.

Please see Disclaimer on site: http://Disclaimer.QualityStocks.net

Duration : 0:4:20

Read the rest of this entry »

How children benefit from horse therapy in this free video clip.

Expert: Connie Weinsoff
Contact: www.hearts.homestead.com
Bio: Connie Weinsoff is the Executive Director at Hearts Adaptive Therapeutic Horseback Riding Center. She is a NARHA Certified Advanced Instructor.
Filmmaker: Diana Bacon

Duration : 0:2:24

Read the rest of this entry »

A case study of a disabled woman on therapeutic horseback riding in this free video clip.

Expert: Connie Weinsoff
Contact: www.hearts.homestead.com
Bio: Connie Weinsoff is the Executive Director at Hearts Adaptive Therapeutic Horseback Riding Center. She is a NARHA Certified Advanced Instructor.
Filmmaker: Diana Bacon

Duration : 0:1:32

Read the rest of this entry »

In this 1955 film, a CIA-funded study examines medical experiments to determine the efficacy of LSD-25 and MER 17 (Frenquel) on treating psychosis.

Lysergic acid diethylamide (LSD-25, LSD), formerly lysergide, commonly known as acid, is a semisynthetic psychedelic drug of the ergoline and tryptamine families. LSD is non-addictive, non-toxic, and is well known for its psychological effects which can include altered thinking processes, closed and open eye visuals, synaesthesia, a sense of time distortion, ego death and spiritual experiences, as well as for its key role in 1960s counterculture. It is used mainly by psychonauts as an entheogen and in psychedelic therapy.

LSD was first synthesized by Albert Hofmann in 1938 from ergot, a grain fungus that typically grows on rye. The short form LSD comes from its early code name LSD-25, which is an abbreviation for the German “Lysergsäure-diethylamid” followed by a sequential number. LSD is sensitive to oxygen, ultraviolet light, and chlorine, especially in solution, though its potency may last for years if it is stored away from light and moisture at low temperature. In pure form it is a colourless, odourless, and mildly bitter solid. LSD is typically delivered orally, usually on a substrate such as absorbent blotter paper, a sugar cube, or gelatin. In its liquid form, it can also be administered by intramuscular or intravenous injection. LSD is very potent, with 2030 µg (micrograms) being the threshold dose.

Introduced by Sandoz Laboratories, with trade-name Delysid, as a drug with various psychiatric uses in 1947, LSD quickly became a therapeutic agent that appeared to show great promise. However, the emerging recreational use of the drug by youth culture in the Western world during the 1960s led to a political firestorm that resulted in its prohibition. A number of organizations—including the Beckley Foundation, MAPS, Heffter Research Institute and the Albert Hofmann Foundation—exist to fund, encourage and coordinate research into its medicinal uses.

LSD was first synthesized on November 16, 1938 by Swiss chemist Dr. Albert Hofmann at the Sandoz Laboratories in Basel, Switzerland as part of a large research program searching for medically useful ergot alkaloid derivatives. LSD’s psychedelic properties were discovered 5 years later when Hofmann accidentally ingested an unknown quantity of the chemical. The first intentional ingestion of LSD occurred on April 19, 1943, when Dr. Hofmann ingested 250 µg of LSD. He hypothesized this would be a threshold dose based on the dosages of other ergot alkaloids. Hofmann found the effects to be much stronger than he anticipated. Sandoz Laboratories introduced LSD as a psychiatric drug in 1947.

Beginning in the 1950s the US Central Intelligence Agency began a research program code named Project MKULTRA. Experiments included administering LSD to CIA employees, military personnel, doctors, other government agents, prostitutes, mentally ill patients, and members of the general public in order to study their reactions, usually without the subject’s knowledge. The project was revealed in the US congressional Rockefeller Commission report in 1975.

In 1963 the Sandoz patents expired on LSD. Also in 1963, the US Food and Drug Administration classified LSD as an Investigational New Drug, which meant new restrictions on medical and scientific use. Several figures, including Aldous Huxley, Timothy Leary, and Al Hubbard, began to advocate the use of LSD. LSD became central to the counterculture of the 1960s. On October 24, 1968, possession of LSD was made illegal in the United States. The last FDA approved human study with LSD, for use in dying cancer patients, ended in 1980. Legally approved and regulated psychiatric use of LSD continued in Switzerland until 1993. Today, medical research is resuming around the world.

Duration : 0:10:59

Read the rest of this entry »

How to mount a horse in this free video clip about Therapeutic Riding.

Expert: Connie Weinsoff
Contact: www.hearts.homestead.com
Bio: Connie Weinsoff is the Executive Director at Hearts Adaptive Therapeutic Horseback Riding Center. She is a NARHA Certified Advanced Instructor.
Filmmaker: Diana Bacon

Duration : 0:1:26

Read the rest of this entry »

Excerpts from “The Mind – Benders: Lysergic acid diethylamide (LSD) and the Hallucinogens”. This film explores the history of hallucinogenic drugs, and specifically the effects of lysergic acid diethylamide (LSD). Combining graphics that suggest a hallucinogenic experience, snippets of interviews with users (who explain their reasons for taking the drug) and doctors, and taped sessions of research with volunteers, the film delves into the destructive uses of the drug. Producer: National Archives and Records Administration. Creative Commons license: Public Domain

Chemist Albert Hofmann, working at the Sandoz Corporation pharmaceutical laboratory in Switzerland, first synthesized LSD in 1938. He was conducting research on possible medical applications of various lysergic acid compounds derived from ergot, a fungus that develops on rye grass. Searching for compounds with therapeutic value, Hofmann created more than two dozen ergot-derived synthetic molecules.

LSD is sold on the street in tablets, capsules, and occasionally in liquid form. It is an odorless and colorless substance with a slightly bitter taste that is usually ingested orally. It is often added to absorbent paper, such as blotter paper, and divided into small decorated squares, with each square representing one dose.

CONTROL STATUS

LSD is a Schedule I substance under the Controlled Substances Act. Schedule I drugs, which include heroin and MDMA, have a high potential for abuse and serve no legitimate medical purpose. Its two precursors lysergic acid and lysergic acid amide are both in Schedule III of the CSA. The LSD precursors ergotamine and ergonovine are List I chemicals.

STREET TERMS

Acid, blotter acid, window pane, dots, mellow yellow

SHORT-TERM EFFECTS

The short-term effects of LSD are unpredictable. They depend on the amount of the drug taken; the user’s personality, mood, and expectations; and the surroundings in which the drug is used. Usually, the user feels the first effects of the drug within 30 to 90 minutes of ingestion. These experiences last for extended periods of time and typically begin to clear after about 12 hours. The physical effects include dilated pupils, higher body temperature, increased heart rate and blood pressure, sweating, loss of appetite, sleeplessness, dry mouth, and tremors. Sensations may seem to “cross over” for the user, giving the feeling of hearing colors and seeing sounds. If taken in a large enough dose, the drug produces delusions and visual hallucinations.

LONG-TERM EFFECTS

LSD users often have flashbacks, during which certain aspects of their LSD experience recur even though they have stopped taking the drug. In addition, LSD users may develop long-lasting psychoses, such as schizophrenia or severe depression. LSD is not considered an addictive drug – that is, it does not produce compulsive drug-seeking behavior as cocaine, heroin, and methamphetamine do. However, LSD users may develop tolerance to the drug, meaning that they must consume progressively larger doses of the drug in order to continue to experience the hallucinogenic effects that they seek.

TRAFFICKING TRENDS

LSD trafficking and abuse have decreased sharply since 2000, and a resurgence does not appear likely in the near term. National-level data regarding LSD availability (such as LSD seizures and LSD-related arrests) show a sharp decrease since 2000. LSD seizures, for example, decreased 100 percent from 2000 through 2005, and LSD-related arrests decreased 84.9 percent from 2000 through 2004 (see 2006 National Drug Threat Assessment Appendix B, Table 4 and Table 5). Demand for LSD also has decreased sharply since 2000, as reflected in national-level prevalence studies. In fact, Monitoring the Future (MTF) and National Survey on Drug Use and Health (NSDUH) data show that rates of past year use for LSD have decreased significantly for nearly every sampled age group (see 2006 National Drug Threat Assessment Appendix B, Table 1 and Table 2). Production of the drug also appears to be limited–with no reported laboratory seizures in 2004–and controlled by a relatively small number of experienced chemists. Moreover, LSD distribution appears to be very limited in most areas of the country. As such, resurgence in widespread LSD distribution is unlikely in the near term.

USE/USER POPULATION

LSD is abused by teenagers and young adults in connection with raves, nightclubs and concert settings.

Approximately 1.9% of eighth graders, 2.5% of tenth graders, and 3.5% of twelfth graders surveyed as part of the 2005 Monitoring the Future study reported lifetime use of LSD. Approximately 44% of eighth graders, 60.8% of tenth graders, and 69.9% of twelfth graders surveyed in 2005 reported that taking LSD regularly was a “great risk.” Additional survey results indicate that 5.6% of college students and 13.4% of young adults reported lifetime use of LSD.

Duration : 0:18:17

Read the rest of this entry »

Therapeutic Rider qualifications in this free video clip.

Expert: Connie Weinsoff
Contact: www.hearts.homestead.com
Bio: Connie Weinsoff is the Executive Director at Hearts Adaptive Therapeutic Horseback Riding Center. She is a NARHA Certified Advanced Instructor.
Filmmaker: Diana Bacon

Duration : 0:1:21

Read the rest of this entry »